Speaker & Presentation Information

Spring Quarterly Pathology / Immunohistochemistry Conference Featuring Torsten Nielsen, MD, PhD

Dr. Torsten O. Nielsen of the University of British Columbia in Vancouver, Canada, will present "Translating Expression Profiles into Clinical Care" at the Quarterly Pathology / Immunohistochemistry Conference on Thursday, May 11, 2006 at PhenoPath Laboratories.  The format of the conference is a social hour commencing at 6:30 p.m., followed by the lecture at 7:30 p.m. A light catered dinner will be provided during the social hour.

Dr. Nielsen’s research interests involve understanding how molecular changes in cancer cells impact upon diagnosis, prognosis, and treatment, and in developing new and clinically practical molecular diagnostics and targeted therapies for human cancer, particularly sarcomas and breast cancer. His active research is in the areas of gene expression profiling, tissue microarrays and experimental therapeutics. As one of the directors of the Genetic Pathology Evaluation Centre in Vancouver, he leads several projects focusing on the validation and clinical correlation of results from gene expression profiling of sarcomas and breast cancer (including the basal-like phenotype).  Dr. Nielsen will be speaking on how expression profile results can be applied in practice using techniques (immunohistochemistry, FISH, PCR) that are applicable on standard paraffin material and accessible/affordable for hospital laboratories.

Torsten Nielsen completed his MD/PhD at McGill University and is currently an Assistant Professor and clinician-scientist in the Departments of Pathology and Orthopaedics at the University of British Columbia. He is based at the Vancouver General Hospital and British Columbia Cancer Agency. The spring Quarterly Conference will be co-sponsored by Dako Corporation.

Back to top